These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874 [TBL] [Abstract][Full Text] [Related]
5. Natalizumab for relapsing multiple sclerosis. Meyer MA N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16742009 [No Abstract] [Full Text] [Related]
6. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. Jilek S; Jaquiéry E; Hirsch HH; Lysandropoulos A; Canales M; Guignard L; Schluep M; Pantaleo G; Du Pasquier RA Lancet Neurol; 2010 Mar; 9(3):264-72. PubMed ID: 20117055 [TBL] [Abstract][Full Text] [Related]
7. Natalizumab and progressive multifocal leukoencephalopathy: highlights of the International Workshop on JC Virus/PML and Multiple Sclerosis, June 3-4, 2005, Philadelphia PA. Tyler KL; Khalili K Rev Neurol Dis; 2005; 2(3):144-9. PubMed ID: 16400315 [No Abstract] [Full Text] [Related]
8. JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy? Verbeeck J; Van Assche G; Ryding J; Wollants E; Rans K; Vermeire S; Pourkarim MR; Noman M; Dillner J; Van Ranst M; Rutgeerts P Gut; 2008 Oct; 57(10):1393-7. PubMed ID: 18436577 [TBL] [Abstract][Full Text] [Related]
9. Asymptomatic reactivation of JC virus in patients treated with natalizumab. Warnke C; Adams O; Kieseier BC N Engl J Med; 2009 Dec; 361(25):2489; author reply 2489-90. PubMed ID: 20050216 [No Abstract] [Full Text] [Related]
10. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. Lindå H; von Heijne A; Major EO; Ryschkewitsch C; Berg J; Olsson T; Martin C N Engl J Med; 2009 Sep; 361(11):1081-7. PubMed ID: 19741229 [TBL] [Abstract][Full Text] [Related]
15. Natalizumab and progressive multifocal leukoencephalopathy. Adelman B; Sandrock A; Panzara MA N Engl J Med; 2005 Jul; 353(4):432-3. PubMed ID: 15947083 [No Abstract] [Full Text] [Related]
16. Reemergence of PML in natalizumab-treated patients--new cases, same concerns. Major EO N Engl J Med; 2009 Sep; 361(11):1041-3. PubMed ID: 19741226 [No Abstract] [Full Text] [Related]
17. Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. Berger JR; Koralnik IJ N Engl J Med; 2005 Jul; 353(4):414-6. PubMed ID: 15947082 [No Abstract] [Full Text] [Related]
19. Natalizumab for relapsing multiple sclerosis. Jeffery DR N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16742008 [No Abstract] [Full Text] [Related]
20. JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML. Berger JR AIDS; 2003 Jul; 17(10):1557-9. PubMed ID: 12824794 [No Abstract] [Full Text] [Related] [Next] [New Search]